Literature DB >> 22383309

Trans fat, aspirin, and ischemic stroke in postmenopausal women.

Sirin Yaemsiri1, Souvik Sen, Lesley Tinker, Wayne Rosamond, Sylvia Wassertheil-Smoller, Ka He.   

Abstract

OBJECTIVE: To examine the associations between dietary fat intake and ischemic stroke among postmenopausal women.
METHODS: We conducted a prospective cohort study of 87,025 generally healthy postmenopausal women (age, 50-79 years) enrolled in the Women's Health Initiative Observational Study. Repeated and validated dietary assessments were done using a self-administered food frequency questionnaire. We used Cox proportional hazards models to estimate hazard ratios (HRs) of ischemic stroke based on quintiles of the cumulative average of fat intake.
RESULTS: We documented 1,049 incident cases of ischemic stroke over 663,041 person-years of follow-up. Women in the highest quintile of trans fat intake had a significantly higher incidence of ischemic stroke (HR, 1.39; 95% confidence interval [CI], 1.08-1.79; p-trend = 0.048) compared with women in the lowest quintile, while controlling for multiple covariates. The observed association was modified by aspirin use (p-interaction = 0.02). The HR was 1.66 (95% CI, 1.21-2.36; p-trend < 0.01) among baseline non-aspirin users (n = 67,288) and 0.95 (95% CI, 0.60-1.48; p-trend = 0.43) among aspirin users (n = 19,736). No significant associations were found between intakes of saturated, monounsaturated, or polyunsaturated fat and ischemic stroke or any ischemic stroke subtypes.
INTERPRETATION: In this large cohort of postmenopausal women, higher intake of trans fat was associated with incident ischemic stroke independent of major lifestyle/dietary factors. Aspirin use may attenuate the potential adverse effect of trans fat intake on ischemic stroke.
Copyright © 2012 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22383309      PMCID: PMC3371162          DOI: 10.1002/ana.23555

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  28 in total

Review 1.  Statins and stroke: evidence for cholesterol-independent effects.

Authors:  P Di Napoli; A A Taccardi; M Oliver; R De Caterina
Journal:  Eur Heart J       Date:  2002-12       Impact factor: 29.983

2.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative.

Authors:  J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

3.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Authors:  Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321

4.  Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.

Authors:  L B Goldstein; M R Jones; D B Matchar; L J Edwards; J Hoff; V Chilukuri; S B Armstrong; R D Horner
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

Review 5.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Kirsten Ward; Theresa Hm Moore; Margaret Burke; George Davey Smith; Juan-Pablo Casas; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

6.  Prospective study of fat and protein intake and risk of intraparenchymal hemorrhage in women.

Authors:  H Iso; M J Stampfer; J E Manson; K Rexrode; F Hu; C H Hennekens; G A Colditz; F E Speizer; W C Willett
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690

Review 7.  Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.

Authors:  Jean-Christophe Corvol; Anissa Bouzamondo; Marc Sirol; Jean-Sébastien Hulot; Paola Sanchez; Philippe Lechat
Journal:  Arch Intern Med       Date:  2003-03-24

8.  Linoleic acid, other fatty acids, and the risk of stroke.

Authors:  Hiroyasu Iso; Shinichi Sato; Utako Umemura; Minako Kudo; Kazuko Koike; Akihiko Kitamura; Hironori Imano; Tomonori Okamura; Yoshihiko Naito; Takashi Shimamoto
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

9.  Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study.

Authors:  Ka He; Anwar Merchant; Eric B Rimm; Bernard A Rosner; Meir J Stampfer; Walter C Willett; Alberto Ascherio
Journal:  BMJ       Date:  2003-10-04

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

View more
  22 in total

1.  Nut consumption and risk of stroke.

Authors:  Zhizhong Zhang; Gelin Xu; Yongyue Wei; Wusheng Zhu; Xinfeng Liu
Journal:  Eur J Epidemiol       Date:  2015-02-28       Impact factor: 8.082

2.  Hospital Admissions for Myocardial Infarction and Stroke Before and After the Trans-Fatty Acid Restrictions in New York.

Authors:  Eric J Brandt; Rebecca Myerson; Marcelo Coca Perraillon; Tamar S Polonsky
Journal:  JAMA Cardiol       Date:  2017-06-01       Impact factor: 14.676

3.  Intake of trans fat and incidence of stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.

Authors:  James N Kiage; Peter D Merrill; Suzanne E Judd; Ka He; Loren Lipworth; Mary Cushman; Virginia J Howard; Edmond K Kabagambe
Journal:  Am J Clin Nutr       Date:  2014-02-12       Impact factor: 7.045

4.  Can dietary saturated fat be beneficial in prevention of stroke risk? A meta-analysis.

Authors:  Pengfei Cheng; Jingxia Wang; Weihua Shao; Meiling Liu; Hui Zhang
Journal:  Neurol Sci       Date:  2016-03-15       Impact factor: 3.307

Review 5.  Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis.

Authors:  Jang Yel Shin; Pengcheng Xun; Yasuyuki Nakamura; Ka He
Journal:  Am J Clin Nutr       Date:  2013-05-15       Impact factor: 7.045

6.  Serum fatty acids and incidence of ischemic stroke among postmenopausal women.

Authors:  Sirin Yaemsiri; Souvik Sen; Lesley F Tinker; Whitney R Robinson; Rhobert W Evans; Wayne Rosamond; Sylvia Wasserthiel-Smoller; Ka He
Journal:  Stroke       Date:  2013-07-30       Impact factor: 7.914

7.  Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort.

Authors:  James N Kiage; Peter D Merrill; Cody J Robinson; Yue Cao; Talha A Malik; Barrett C Hundley; Ping Lao; Suzanne E Judd; Mary Cushman; Virginia J Howard; Edmond K Kabagambe
Journal:  Am J Clin Nutr       Date:  2013-04-03       Impact factor: 7.045

8.  Egg consumption and cardiovascular risk: a dose-response meta-analysis of prospective cohort studies.

Authors:  Miguel A Martinez-Gonzalez; Giuseppe Grosso; Justyna Godos; Agnieszka Micek; Tomasz Brzostek; Estefania Toledo; Licia Iacoviello; Arne Astrup; Oscar H Franco; Fabio Galvano
Journal:  Eur J Nutr       Date:  2020-08-31       Impact factor: 5.614

Review 9.  Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies.

Authors:  Russell J de Souza; Andrew Mente; Adriana Maroleanu; Adrian I Cozma; Vanessa Ha; Teruko Kishibe; Elizabeth Uleryk; Patrick Budylowski; Holger Schünemann; Joseph Beyene; Sonia S Anand
Journal:  BMJ       Date:  2015-08-11

10.  Effect of trans fatty acid intake on LC-MS and NMR plasma profiles.

Authors:  Gözde Gürdeniz; Daniela Rago; Nathalie Tommerup Bendsen; Francesco Savorani; Arne Astrup; Lars O Dragsted
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.